{"id":1363,"date":"2020-06-16T02:18:55","date_gmt":"2020-06-16T02:18:55","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1363"},"modified":"2023-08-29T17:45:41","modified_gmt":"2023-08-29T17:45:41","slug":"race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1363","title":{"rendered":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c"},"content":{"rendered":"<p>\u4e13\u4e1a\u5236\u836f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=RAC&amp;lang=cn\">Race Oncology (ASX: RAC)<\/a>\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002<\/p>\n<p>\u8fd9\u9879\u5728\u4ee5\u8272\u5217\u8c22\u5df4\u533b\u7597\u4e2d\u5fc3\uff08Sheba Medical Centre\uff09\u8fdb\u884c\u7684\u5f00\u653e\u6807\u7b7e\u5355\u836f\u8bd5\u9a8c\u7814\u7a76\u4e86\u5e73\u5747\u670910\u540d\u60a3\u8005\uff0c\u4ed6\u4eec\u4e4b\u524d\u7684\u4e09\u79cd\u6cbb\u7597\u90fd\u5931\u8d25\u4e86\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u62a5\u544a\u79f0\uff0cBisantrene\u7684\u8010\u53d7\u6027\u826f\u597d\uff0c\u6ca1\u6709\u610f\u5916\u6216\u4e25\u91cd\u7684\u6bd2\u6027\u3002<\/p>\n<h2>\u75c5\u4eba\u7684\u7ed3\u679c<\/h2>\n<p>\u5355\u7597\u7a0b\u6cbb\u7597\u540e\uff0c\u8be5\u836f\u7684\u4e34\u5e8a\u603b\u6709\u6548\u7387\u4e3a40%\uff0c\u5176\u4e2d1\u4f8b\u60a3\u8005\u5b8c\u5168\u7f13\u89e3\uff0c3\u4f8b\u60a3\u8005\u90e8\u5206\u7f13\u89e3\u3002<\/p>\n<p>\u4e00\u540d\u60a3\u8005\u63a5\u53d7\u4e86\u5f02\u57fa\u56e0\u5e72\u7ec6\u80de\u79fb\u690d(\u4ece\u57fa\u56e0\u5339\u914d\u7684\u4f9b\u4f53\u4e2d\u6350\u8d60\u7ec6\u80de\u7ed9\u60a3\u8005)\uff0c\u5728\u6cbb\u7597\u671f\u95f4\u6ca1\u6709\u4ece\u7814\u7a76\u4e2d\u53d6\u51fa\u6216\u53d6\u51fa\u3002<\/p>\n<p>\u8be5\u836f\u7269\u57284\u540d\u9ad3\u5916(\u9aa8\u9ad3\u5916)\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u8eab\u4e0a\u4e5f\u6709\u663e\u8457\u7684\u6d3b\u6027\uff0c\u5982\u76ae\u80a4\u767d\u8840\u75c5\u3001\u7eff\u7624\u548c\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u8fd9\u4e9b\u5728\u5386\u53f2\u4e0a\u90fd\u5f88\u96be\u6cbb\u7597\u3002<\/p>\n<h2>\u4e0d\u826f\u4e8b\u4ef6<\/h2>\n<p>\u6700\u5e38\u62a5\u9053\u7684\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u662f\u8840\u5c0f\u677f\u51cf\u5c11(\u4f4e\u8840\u5c0f\u677f)\u548c\u7c98\u819c\u708e(\u53e3\u8154\u6e83\u75a1)\uff0c\u8fd9\u4e24\u79cd\u90fd\u662f\u84bd\u73af\u7c7b\u548c\u84bd\u7c7b\u5316\u7597\u836f\u7269\u7684\u526f\u4f5c\u7528\u3002<\/p>\n<p>1\u4f8b\u60a3\u8005\u51fa\u73b0\u4e00\u8fc7\u6027\u4e00\u7ea7\u80be\u6bd2\u6027\uff0c\u672a\u89c2\u5bdf\u5230\u809d\u6bd2\u6027\u3002<\/p>\n<p>Race\u8bf4\u5728\u6cbb\u7597\u8fc7\u7a0b\u4e2d\u6ca1\u6709\u4efb\u4f55\u60a3\u8005\u51fa\u73b0\u8fc7\u654f\u53cd\u5e94\u3002\u8fd9\u79cd\u7c7b\u578b\u7684\u53cd\u5e94\u662f\u5728\u5386\u53f2\u8bd5\u9a8c\u4e2d\u7ecf\u5e38\u89c2\u5bdf\u5230\u7684\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002<\/p>\n<h2>\u6cbb\u7597\u7684\u6311\u6218<\/h2>\n<p>\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u4ecd\u7136\u662f\u4e00\u4e2a\u91cd\u5927\u7684\u6cbb\u7597\u6311\u6218\u3002<\/p>\n<p>\u867d\u7136\u8fd1\u5e74\u6765\u968f\u7740\u65b0\u7684\u9776\u5411\u836f\u7269\u7684\u5f15\u5165\uff0c\u5df2\u7ecf\u53d6\u5f97\u4e86\u6709\u610f\u4e49\u7684\u8fdb\u5c55\uff0c\u4f46\u53d1\u8868\u7684\u7814\u7a76\u58f0\u79f0\u4e34\u5e8a\u7ed3\u679c\u4ecd\u7136\u4e0d\u4ee4\u4eba\u6ee1\u610f\u3002<\/p>\n<p>Bisantrene\u662f\u4e00\u79cd\u5c0f\u5206\u5b50\u6297\u764c\u836f\u7269\uff0c\u4e0e\u84bd\u73af\u7c7b\u836f\u7269\u76f8\u5173\uff0c\u84bd\u73af\u7c7b\u836f\u7269\u662f\u6700\u5e7f\u6cdb\u4f7f\u7528\u7684\u5316\u7597\u836f\u7269\u3002<\/p>\n<p>\u4e0e\u84bd\u73af\u7c7b\u836f\u7269\u4e0d\u540c\uff0c\u5b83\u53ef\u4ee5\u5927\u5927\u964d\u4f4e\u5fc3\u810f\u6bd2\u6027(\u5fc3\u810f\u635f\u4f24)\u7684\u98ce\u9669\uff0c\u8fd9\u610f\u5473\u7740\u5b83\u53ef\u4ee5\u7528\u4e8e\u90a3\u4e9b\u5df2\u7ecf\u4f7f\u7528\u84bd\u73af\u7c7b\u836f\u7269\u8fbe\u5230\u5fc3\u810f\u6bd2\u6027\u6781\u9650\u7684\u60a3\u8005\uff0c\u6216\u8005\u7531\u4e8e\u73b0\u6709\u5fc3\u810f\u72b6\u51b5\u3001\u5e74\u9f84\u6216\u5176\u4ed6\u56e0\u7d20\u4e0d\u80fd\u8010\u53d7\u84bd\u73af\u7c7b\u836f\u7269\u7684\u60a3\u8005\u3002<\/p>\n<p>\u572820\u4e16\u7eaa80\u5e74\u4ee3\u548c90\u5e74\u4ee3\u671f\u95f4\uff0cBisantrene\u8fdb\u884c\u4e8640\u591a\u6b21II\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u7814\u53d1\u6295\u5165\u9ad8\u8fbe2\u4ebf\u6fb3\u5143\uff0c\u540e\u6765\u5728\u4e00\u7cfb\u5217\u5927\u578b\u5236\u836f\u5408\u5e76\u4e2d\u201c\u5931\u53bb\u201d\u4e86\u5b83\u3002<\/p>\n<h2>\u5386\u53f2\u7684\u7ed3\u679c<\/h2>\n<p>Race\u4e34\u5e8a\u54a8\u8be2\u59d4\u5458\u4f1a\u4e3b\u5e2d\u3001\u4e34\u5e8a\u767d\u8840\u75c5\u548c\u5e72\u7ec6\u80de\u7814\u7a76\u7684\u56fd\u9645\u6743\u5a01Borje Andersson\u6559\u6388\u8bf4\uff0c\u8be5\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u4f7f\u7528\u4e0d\u540c\u914d\u65b9\u7684Bisantrene\u7684\u5386\u53f2\u7ed3\u679c\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u867d\u7136\u572820\u4e16\u7eaa80\u5e74\u4ee3\uff0cBisantrene\u5df2\u7ecf\u88ab\u8bc1\u660e\u662f\u6cbb\u7597\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u6709\u6548\u62a2\u6551\u836f\u7269\uff0c\u4f46\u6211\u4eec\u62e5\u6709\u7684\u4e34\u5e8a\u6570\u636e\u662f\u9648\u65e7\u7684\u3002\u201d<\/p>\n<p>\u201c\u5bf9\u6211\u4eec\u6765\u8bf4\uff0c\u7528\u76ee\u524d\u7684\u914d\u65b9\u6309\u7167\u4eca\u5929\u7684\u6807\u51c6\u6765\u7814\u7a76\u5b83\u662f\u5f88\u91cd\u8981\u7684\uff0c\u8fd9\u6837\u6211\u4eec\u5c31\u53ef\u4ee5\u786e\u8ba4\u6211\u4eec\u91cd\u65b0\u5229\u7528\u8fd9\u79cd\u836f\u7269\u7684\u7b56\u7565\u662f\u5426\u5408\u7406\u3002\u201d<\/p>\n<p>Andersson\u6559\u6388\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u8fd8\u60f3\u786e\u8ba4\uff0cBisantrene\u4ecd\u7136\u53ef\u4ee5\u5728\u4e25\u91cd\u9884\u5904\u7406\u7684\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u9ad8\u5ea6\u865a\u5f31\u60a3\u8005\u4eba\u7fa4\u4e2d\u4ea7\u751f\u6709\u610f\u4e49\u7684\u5e94\u7b54\u7387\u3002\u201d<\/p>\n<p>\u8be5\u7814\u7a76\u53d1\u73b0\u767d\u8840\u75c5\u60a3\u8005\u7684\u75be\u75c5\u8d1f\u62c5\u964d\u4f4e\uff0c40%\u7684\u60a3\u8005\u603b\u4f53\u6709\u6548\u7387\u964d\u4f4e\u3002<\/p>\n<p>Andersson\u6559\u6388\u8bf4:\u201c\u867d\u7136\u6211\u4eec\u5fc5\u987b\u8fdb\u4e00\u6b65\u7814\u7a76\u8be5\u836f\u7269\uff0c\u4f46\u9274\u4e8e\u8fd9\u79cd\u53cd\u5e94\uff0c\u4ee5Bisantrene\u4e3a\u57fa\u7840\u7684\u6cbb\u7597\u53ef\u80fd\u6709\u6f5c\u529b\u6210\u4e3a\u60a3\u8005\u8fdb\u884c\u5f02\u57fa\u56e0\u5e72\u7ec6\u80de\u79fb\u690d\u7684\u91cd\u8981\u6865\u6881\u3002\u201d<\/p>\n<h2>\u73b0\u4ee3\u80cc\u666f\u4e0b<\/h2>\n<p>Race\u9996\u5e2d\u79d1\u5b66\u5b98Daniel Tillett\u535a\u58eb\u8bf4II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4e00\u4e2a\u5173\u952e\u7126\u70b9\u662f\u786e\u5b9a\u5728\u73b0\u4ee3\u80cc\u666f\u4e0bBisantrene\u7684\u5b89\u5168\u6027\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u4ece\u5b89\u5168\u6027\u548c\u6d3b\u52a8\u6027\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u8fd9\u4e9b\u7ed3\u679c\u662f\u4ee4\u4eba\u6ee1\u610f\u7684\uff0c\u7279\u522b\u662f\u8003\u8651\u5230\u8bd5\u9a8c\u4e2d\u5305\u542b\u7684\u5177\u6709\u4e34\u5e8a\u6311\u6218\u6027\u7684\u60a3\u8005\u7fa4\u4f53\u3002\u201d<\/p>\n<p>Tillett\u535a\u58eb\u8865\u5145\u8bf4:\u201c\u4e0e\u84bd\u73af\u7c7b\u7b49\u5176\u4ed6\u5e38\u7528\u5316\u7597\u836f\u7269\u76f8\u6bd4\uff0c\u8be5\u836f\u7269\u7684\u8010\u53d7\u6027\u826f\u597d\uff0c\u8fd9\u662f\u4ee4\u4eba\u9f13\u821e\u7684\uff0c\u540c\u65f6\u5176\u526f\u4f5c\u7528\u4e5f\u7b26\u5408\u6211\u4eec\u5bf9\u8be5\u7c7b\u5316\u7597\u836f\u7269\u7684\u9884\u671f\u3002\u201d<\/p>\n<h2>\u5b89\u5168\u914d\u7f6e\u6587\u4ef6<\/h2>\n<p>Andersson\u6559\u6388\u8bf4\uff0c\u8bd5\u9a8c\u53d1\u73b0Bisantrene\u662f\u4e00\u79cd\u5177\u6709\u53ef\u63a5\u53d7\u7684\u5b89\u5168\u6027\u548c\u6297\u767d\u8840\u75c5\u6d3b\u6027\u7684\u836f\u7269\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u7531\u4e8e\u8fd9\u662f\u4e00\u4e2a\u5f00\u653e\u6807\u7b7e\u7684\u5355\u5242\u8bd5\u9a8c\uff0c\u6211\u4eec\u53ef\u4ee5\u786e\u4fe1\uff0c\u662fBisantrene\u66b4\u9732\u4ea7\u751f\u4e86\u79ef\u6781\u7684\u7ed3\u679c\u3002\u201d<\/p>\n<p>\u201c\u8fd9\u7ec4\u60a3\u8005\u60a3\u6709\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\uff0c\u4e4b\u524d\u5e73\u5747\u4e09\u79cd\u6cbb\u7597\u90fd\u5931\u8d25\u4e86\uff0c\u6240\u4ee5\u4ed6\u4eec\u603b\u662f\u5f88\u96be\u6cbb\u7597\uff0c\u4f46\u4ec5\u4ec5\u4e00\u4e2a\u7597\u7a0b\u7684\u6cbb\u7597\u540e40%\u7684\u603b\u6709\u6548\u7387\u660e\u663e\u8d85\u8fc7\u4e86\u6211\u4eec\u7684\u9884\u671f\u3002\u201d<\/p>\n<p>Andersson\u6559\u6388\u8865\u5145\u8bf4:\u201c\u8fd9\u662f\u4e00\u4e2a\u975e\u5e38\u6709\u5e0c\u671b\u7684\u7ed3\u679c\uff0c\u5b83\u52a0\u5f3a\u4e86\u6211\u4eec\u5bf9\u8fd9\u79cd\u836f\u7269\u7684\u5f00\u53d1\u8ba1\u5212\u3002\u201d<\/p>\n<p>\u4e00\u9879\u5c06Bisantrene\u4e0e\u5176\u4ed6\u6297\u767d\u8840\u75c5\u836f\u7269\u8054\u5408\u4f7f\u7528\u7684\u540e\u7eed\u7814\u7a76\u76ee\u524d\u5df2\u8fdb\u5165\u540e\u671f\u8ba1\u5212\u9636\u6bb5\u3002<\/p>\n<p>\u4e0a\u5348\u4e2d\u6bb5\uff0cRace Oncology\u7684\u80a1\u4ef7\u4e0a\u6da853.97%\uff0c\u81f30.485\u6fb3\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002 \u8fd9\u9879\u5728\u4ee5\u8272\u5217\u8c22\u5df4\u533b\u7597\u4e2d\u5fc3\uff08Sheba Medical Centre\uff09\u8fdb\u884c\u7684\u5f00\u653e\u6807\u7b7e\u5355\u836f\u8bd5\u9a8c\u7814\u7a76\u4e86\u5e73\u5747\u670910\u540d\u60a3\u8005\uff0c\u4ed6\u4eec\u4e4b\u524d\u7684\u4e09\u79cd\u6cbb\u7597\u90fd\u5931\u8d25\u4e86\u3002 \u8be5\u516c\u53f8\u62a5\u544a\u79f0\uff0cBisantrene\u7684\u8010\u53d7\u6027\u826f\u597d\uff0c\u6ca1\u6709\u610f\u5916\u6216\u4e25\u91cd\u7684\u6bd2\u6027\u3002 \u75c5\u4eba\u7684\u7ed3\u679c \u5355\u7597\u7a0b\u6cbb\u7597\u540e\uff0c\u8be5\u836f\u7684\u4e34\u5e8a\u603b\u6709\u6548\u7387\u4e3a40%\uff0c\u5176\u4e2d1\u4f8b\u60a3\u8005\u5b8c\u5168\u7f13\u89e3\uff0c3\u4f8b\u60a3\u8005\u90e8\u5206\u7f13\u89e3\u3002 \u4e00\u540d\u60a3\u8005\u63a5\u53d7\u4e86\u5f02\u57fa\u56e0\u5e72\u7ec6\u80de\u79fb\u690d(\u4ece\u57fa\u56e0\u5339\u914d\u7684\u4f9b\u4f53\u4e2d\u6350\u8d60\u7ec6\u80de\u7ed9\u60a3\u8005)\uff0c\u5728\u6cbb\u7597\u671f\u95f4\u6ca1\u6709\u4ece\u7814\u7a76\u4e2d\u53d6\u51fa\u6216\u53d6\u51fa\u3002 \u8be5\u836f\u7269\u57284\u540d\u9ad3\u5916(\u9aa8\u9ad3\u5916)\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u8eab\u4e0a\u4e5f\u6709\u663e\u8457\u7684\u6d3b\u6027\uff0c\u5982\u76ae\u80a4\u767d\u8840\u75c5\u3001\u7eff\u7624\u548c\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u8fd9\u4e9b\u5728\u5386\u53f2\u4e0a\u90fd\u5f88\u96be\u6cbb\u7597\u3002 \u4e0d\u826f\u4e8b\u4ef6 \u6700\u5e38\u62a5\u9053\u7684\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u662f\u8840\u5c0f\u677f\u51cf\u5c11(\u4f4e\u8840\u5c0f\u677f)\u548c\u7c98\u819c\u708e(\u53e3\u8154\u6e83\u75a1)\uff0c\u8fd9\u4e24\u79cd\u90fd\u662f\u84bd\u73af\u7c7b\u548c\u84bd\u7c7b\u5316\u7597\u836f\u7269\u7684\u526f\u4f5c\u7528\u3002 1\u4f8b\u60a3\u8005\u51fa\u73b0\u4e00\u8fc7\u6027\u4e00\u7ea7\u80be\u6bd2\u6027\uff0c\u672a\u89c2\u5bdf\u5230\u809d\u6bd2\u6027\u3002 Race\u8bf4\u5728\u6cbb\u7597\u8fc7\u7a0b\u4e2d\u6ca1\u6709\u4efb\u4f55\u60a3\u8005\u51fa\u73b0\u8fc7\u654f\u53cd\u5e94\u3002\u8fd9\u79cd\u7c7b\u578b\u7684\u53cd\u5e94\u662f\u5728\u5386\u53f2\u8bd5\u9a8c\u4e2d\u7ecf\u5e38\u89c2\u5bdf\u5230\u7684\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002 \u6cbb\u7597\u7684\u6311\u6218 \u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u4ecd\u7136\u662f\u4e00\u4e2a\u91cd\u5927\u7684\u6cbb\u7597\u6311\u6218\u3002 \u867d\u7136\u8fd1\u5e74\u6765\u968f\u7740\u65b0\u7684\u9776\u5411\u836f\u7269\u7684\u5f15\u5165\uff0c\u5df2\u7ecf\u53d6\u5f97\u4e86\u6709\u610f\u4e49\u7684\u8fdb\u5c55\uff0c\u4f46\u53d1\u8868\u7684\u7814\u7a76\u58f0\u79f0\u4e34\u5e8a\u7ed3\u679c\u4ecd\u7136\u4e0d\u4ee4\u4eba\u6ee1\u610f\u3002 Bisantrene\u662f\u4e00\u79cd\u5c0f\u5206\u5b50\u6297\u764c\u836f\u7269\uff0c\u4e0e\u84bd\u73af\u7c7b\u836f\u7269\u76f8\u5173\uff0c\u84bd\u73af\u7c7b\u836f\u7269\u662f\u6700\u5e7f\u6cdb\u4f7f\u7528\u7684\u5316\u7597\u836f\u7269\u3002 \u4e0e\u84bd\u73af\u7c7b\u836f\u7269\u4e0d\u540c\uff0c\u5b83\u53ef\u4ee5\u5927\u5927\u964d\u4f4e\u5fc3\u810f\u6bd2\u6027(\u5fc3\u810f\u635f\u4f24)\u7684\u98ce\u9669\uff0c\u8fd9\u610f\u5473\u7740\u5b83\u53ef\u4ee5\u7528\u4e8e\u90a3\u4e9b\u5df2\u7ecf\u4f7f\u7528\u84bd\u73af\u7c7b\u836f\u7269\u8fbe\u5230\u5fc3\u810f\u6bd2\u6027\u6781\u9650\u7684\u60a3\u8005\uff0c\u6216\u8005\u7531\u4e8e\u73b0\u6709\u5fc3\u810f\u72b6\u51b5\u3001\u5e74\u9f84\u6216\u5176\u4ed6\u56e0\u7d20\u4e0d\u80fd\u8010\u53d7\u84bd\u73af\u7c7b\u836f\u7269\u7684\u60a3\u8005\u3002 \u572820\u4e16\u7eaa80\u5e74\u4ee3\u548c90\u5e74\u4ee3\u671f\u95f4\uff0cBisantrene\u8fdb\u884c\u4e8640\u591a\u6b21II\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u7814\u53d1\u6295\u5165\u9ad8\u8fbe2\u4ebf\u6fb3\u5143\uff0c\u540e\u6765\u5728\u4e00\u7cfb\u5217\u5927\u578b\u5236\u836f\u5408\u5e76\u4e2d\u201c\u5931\u53bb\u201d\u4e86\u5b83\u3002 \u5386\u53f2\u7684\u7ed3\u679c Race\u4e34\u5e8a\u54a8\u8be2\u59d4\u5458\u4f1a\u4e3b\u5e2d\u3001\u4e34\u5e8a\u767d\u8840\u75c5\u548c\u5e72\u7ec6\u80de\u7814\u7a76\u7684\u56fd\u9645\u6743\u5a01Borje Andersson\u6559\u6388\u8bf4\uff0c\u8be5\u8bd5\u9a8c\u8bc1\u5b9e\u4e86\u4f7f\u7528\u4e0d\u540c\u914d\u65b9\u7684Bisantrene\u7684\u5386\u53f2\u7ed3\u679c\u3002 \u4ed6\u8bf4:\u201c\u867d\u7136\u572820\u4e16\u7eaa80\u5e74\u4ee3\uff0cBisantrene\u5df2\u7ecf\u88ab\u8bc1\u660e\u662f\u6cbb\u7597\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u6709\u6548\u62a2\u6551\u836f\u7269\uff0c\u4f46\u6211\u4eec\u62e5\u6709\u7684\u4e34\u5e8a\u6570\u636e\u662f\u9648\u65e7\u7684\u3002\u201d \u201c\u5bf9\u6211\u4eec\u6765\u8bf4\uff0c\u7528\u76ee\u524d\u7684\u914d\u65b9\u6309\u7167\u4eca\u5929\u7684\u6807\u51c6\u6765\u7814\u7a76\u5b83\u662f\u5f88\u91cd\u8981\u7684\uff0c\u8fd9\u6837\u6211\u4eec\u5c31\u53ef\u4ee5\u786e\u8ba4\u6211\u4eec\u91cd\u65b0\u5229\u7528\u8fd9\u79cd\u836f\u7269\u7684\u7b56\u7565\u662f\u5426\u5408\u7406\u3002\u201d Andersson\u6559\u6388\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u8fd8\u60f3\u786e\u8ba4\uff0cBisantrene\u4ecd\u7136\u53ef\u4ee5\u5728\u4e25\u91cd\u9884\u5904\u7406\u7684\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u9ad8\u5ea6\u865a\u5f31\u60a3\u8005\u4eba\u7fa4\u4e2d\u4ea7\u751f\u6709\u610f\u4e49\u7684\u5e94\u7b54\u7387\u3002\u201d \u8be5\u7814\u7a76\u53d1\u73b0\u767d\u8840\u75c5\u60a3\u8005\u7684\u75be\u75c5\u8d1f\u62c5\u964d\u4f4e\uff0c40%\u7684\u60a3\u8005\u603b\u4f53\u6709\u6548\u7387\u964d\u4f4e\u3002 Andersson\u6559\u6388\u8bf4:\u201c\u867d\u7136\u6211\u4eec\u5fc5\u987b\u8fdb\u4e00\u6b65\u7814\u7a76\u8be5\u836f\u7269\uff0c\u4f46\u9274\u4e8e\u8fd9\u79cd\u53cd\u5e94\uff0c\u4ee5Bisantrene\u4e3a\u57fa\u7840\u7684\u6cbb\u7597\u53ef\u80fd\u6709\u6f5c\u529b\u6210\u4e3a\u60a3\u8005\u8fdb\u884c\u5f02\u57fa\u56e0\u5e72\u7ec6\u80de\u79fb\u690d\u7684\u91cd\u8981\u6865\u6881\u3002\u201d \u73b0\u4ee3\u80cc\u666f\u4e0b Race\u9996\u5e2d\u79d1\u5b66\u5b98Daniel Tillett\u535a\u58eb\u8bf4II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4e00\u4e2a\u5173\u952e\u7126\u70b9\u662f\u786e\u5b9a\u5728\u73b0\u4ee3\u80cc\u666f\u4e0bBisantrene\u7684\u5b89\u5168\u6027\u3002 \u4ed6\u8bf4:\u201c\u4ece\u5b89\u5168\u6027\u548c\u6d3b\u52a8\u6027\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u8fd9\u4e9b\u7ed3\u679c\u662f\u4ee4\u4eba\u6ee1\u610f\u7684\uff0c\u7279\u522b\u662f\u8003\u8651\u5230\u8bd5\u9a8c\u4e2d\u5305\u542b\u7684\u5177\u6709\u4e34\u5e8a\u6311\u6218\u6027\u7684\u60a3\u8005\u7fa4\u4f53\u3002\u201d Tillett\u535a\u58eb\u8865\u5145\u8bf4:\u201c\u4e0e\u84bd\u73af\u7c7b\u7b49\u5176\u4ed6\u5e38\u7528\u5316\u7597\u836f\u7269\u76f8\u6bd4\uff0c\u8be5\u836f\u7269\u7684\u8010\u53d7\u6027\u826f\u597d\uff0c\u8fd9\u662f\u4ee4\u4eba\u9f13\u821e\u7684\uff0c\u540c\u65f6\u5176\u526f\u4f5c\u7528\u4e5f\u7b26\u5408\u6211\u4eec\u5bf9\u8be5\u7c7b\u5316\u7597\u836f\u7269\u7684\u9884\u671f\u3002\u201d \u5b89\u5168\u914d\u7f6e\u6587\u4ef6 Andersson\u6559\u6388\u8bf4\uff0c\u8bd5\u9a8c\u53d1\u73b0Bisantrene\u662f\u4e00\u79cd\u5177\u6709\u53ef\u63a5\u53d7\u7684\u5b89\u5168\u6027\u548c\u6297\u767d\u8840\u75c5\u6d3b\u6027\u7684\u836f\u7269\u3002 \u4ed6\u8bf4:\u201c\u7531\u4e8e\u8fd9\u662f\u4e00\u4e2a\u5f00\u653e\u6807\u7b7e\u7684\u5355\u5242\u8bd5\u9a8c\uff0c\u6211\u4eec\u53ef\u4ee5\u786e\u4fe1\uff0c\u662fBisantrene\u66b4\u9732\u4ea7\u751f\u4e86\u79ef\u6781\u7684\u7ed3\u679c\u3002\u201d \u201c\u8fd9\u7ec4\u60a3\u8005\u60a3\u6709\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\uff0c\u4e4b\u524d\u5e73\u5747\u4e09\u79cd\u6cbb\u7597\u90fd\u5931\u8d25\u4e86\uff0c\u6240\u4ee5\u4ed6\u4eec\u603b\u662f\u5f88\u96be\u6cbb\u7597\uff0c\u4f46\u4ec5\u4ec5\u4e00\u4e2a\u7597\u7a0b\u7684\u6cbb\u7597\u540e40%\u7684\u603b\u6709\u6548\u7387\u660e\u663e\u8d85\u8fc7\u4e86\u6211\u4eec\u7684\u9884\u671f\u3002\u201d Andersson\u6559\u6388\u8865\u5145\u8bf4:\u201c\u8fd9\u662f\u4e00\u4e2a\u975e\u5e38\u6709\u5e0c\u671b\u7684\u7ed3\u679c\uff0c\u5b83\u52a0\u5f3a\u4e86\u6211\u4eec\u5bf9\u8fd9\u79cd\u836f\u7269\u7684\u5f00\u53d1\u8ba1\u5212\u3002\u201d \u4e00\u9879\u5c06Bisantrene\u4e0e\u5176\u4ed6\u6297\u767d\u8840\u75c5\u836f\u7269\u8054\u5408\u4f7f\u7528\u7684\u540e\u7eed\u7814\u7a76\u76ee\u524d\u5df2\u8fdb\u5165\u540e\u671f\u8ba1\u5212\u9636\u6bb5\u3002 \u4e0a\u5348\u4e2d\u6bb5\uff0cRace Oncology\u7684\u80a1\u4ef7\u4e0a\u6da853.97%\uff0c\u81f30.485\u6fb3\u5143\u3002<\/p>\n","protected":false},"author":4,"featured_media":8224,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[341],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c<\/title>\n<meta name=\"description\" content=\"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c\" \/>\n<meta property=\"og:description\" content=\"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-16T02:18:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:45:41+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/06\/Race-Oncology-ASX-RAC-Acute-Myeloid-Leukaemia-bisantrene-Phase-2-clinical-trial.jpg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c\" \/>\n<meta name=\"twitter:description\" content=\"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/06\/Race-Oncology-ASX-RAC-Acute-Myeloid-Leukaemia-bisantrene-Phase-2-clinical-trial.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/\",\"name\":\"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-06-16T02:18:55+00:00\",\"dateModified\":\"2023-08-29T17:45:41+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c","description":"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c","og_description":"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/","og_site_name":"smallcapsCN","article_published_time":"2020-06-16T02:18:55+00:00","article_modified_time":"2023-08-29T17:45:41+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/06\/Race-Oncology-ASX-RAC-Acute-Myeloid-Leukaemia-bisantrene-Phase-2-clinical-trial.jpg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c","twitter_description":"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/06\/Race-Oncology-ASX-RAC-Acute-Myeloid-Leukaemia-bisantrene-Phase-2-clinical-trial.jpg","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/","url":"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/","name":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-06-16T02:18:55+00:00","dateModified":"2023-08-29T17:45:41+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u4e13\u4e1a\u5236\u836f\u516c\u53f8Race Oncology (ASX: RAC)\u62a5\u9053\u4e86\u4e00\u9879\u7814\u7a76\u8005\u53d1\u8d77\u7684\u5177\u6709\u5386\u53f2\u610f\u4e49\u7684\u764c\u75c7\u836f\u7269Bisantrene\u5bf9\u590d\u53d1\u6216\u96be\u6cbb\u6027\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9633\u6027\u6570\u636e\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/race-oncology-results-bisantrene-drug-trial-patients-advanced-acute-myeloid-leukaemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Race Oncology\u8bc1\u5b9e\u4e86Bisantrene\u836f\u7269\u8bd5\u9a8c\u5bf9\u665a\u671f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u60a3\u8005\u7684\u9633\u6027\u7ed3\u679c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1363"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1363"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1363\/revisions"}],"predecessor-version":[{"id":8223,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1363\/revisions\/8223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8224"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}